搜索临床试验以:glembatumumab vedotin 和 PD-1 靶向检查点抑制剂(nivolumab 或 pembrolizumab)
总计638个结果
-
Chinese PLA General Hospital未知
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Merck Sharp & Dohme LLC; Astellas Pharma Inc; Seagen Inc.尚未招聘
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Merck Sharp & Dohme LLC招聘中
-
Second Affiliated Hospital of Soochow UniversitySciClone Pharmaceuticals招聘中
-
Bristol-Myers Squibb招聘中
-
Second Affiliated Hospital, School of Medicine,...招聘中颈动脉斑块 | 斑块,动脉粥样硬化 | 免疫检查点抑制剂 | 程序性细胞死亡蛋白 1 抑制剂 | 颈内动脉内膜中层厚度中国
-
Bristol-Myers SquibbOno Pharmaceutical Co. Ltd; Seagen Inc.终止
-
PfizerMerck Sharpe & Dohme LLC招聘中黑色素瘤意大利, 西班牙, 捷克语, 德国, 斯洛伐克, 波兰, 英国
-
Tianjin Medical University Cancer Institute and...招聘中
-
National Cancer Institute (NCI)尚未招聘II 期头颈鳞状细胞癌 | III 期头颈部鳞状细胞癌 | 头颈第四期鳞状细胞癌美国
-
Dana-Farber Cancer InstitutePartner Therapeutics (PTx)撤销
-
SethiMerck Sharp & Dohme LLC招聘中
-
University of Michigan Rogel Cancer Center尚未招聘
-
Sixth Affiliated Hospital, Sun Yat-sen University招聘中
-
Janssen Research & Development, LLC招聘中复发/难治性多发性骨髓瘤美国, 德国, 西班牙, 法国
-
University College, LondonJP Moulton Charitable Foundation招聘中
-
Cancer Institute and Hospital, Chinese Academy...The First Affiliated Hospital with Nanjing Medical University; Fujian Cancer Hospital; Henan Cancer... 和其他合作者招聘中
-
Gustave Roussy, Cancer Campus, Grand Paris招聘中复发/难治性 ALK+ 间变性大细胞淋巴瘤法国, 丹麦, 荷兰
-
Coordination Pharmaceuticals, Inc.University of Illinois at Chicago招聘中
-
Universitaire Ziekenhuizen KU LeuvenKU Leuven招聘中
-
University of Wisconsin, MadisonBristol-Myers Squibb; National Cancer Institute (NCI); AnYxis Immuno-Oncology GmbH; Provenance Biopharmaceuticals暂停
-
Hunan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.未知
-
The Fourth Affiliated Hospital of Zhejiang University...招聘中
-
Guangxi Medical UniversityWuzhou Red Cross Hospital; Wuhan Union Hospital, China; Yunnan Cancer Hospital; Hainan People's... 和其他合作者尚未招聘鼻咽癌 | 新辅助治疗 | PD-1抑制剂
-
Second Affiliated Hospital of Soochow University招聘中
-
The First Affiliated Hospital of Soochow UniversityShanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd未知